Research > ETFs > ETF / ETP Commentary > 

Japan ETFs Could Face Lull Then Notch More Gains

  • Related Symbols
  • DXJ
Japan stocks and related ETFs proved effective at pricing in and were somewhat responsive to last week’s presidential election results. For its part, the WisdomTree Japan Hedged Equity ETF DXJ gained 1.70% for the month ending November 14.More recently, DXJ and other Japan ETFs experienced profit-taking following Election Day in the U.S. However, it easily outpaced the unhedged MSCI Japan Index. That could be the symptom of a “nervous lull” as Nikko Asset Management puts it. But the money manager believes Japan stocks will regain their bullish ways. Some of the post-election jitters displayed by investors as it relates to Japan equities are attributable to President-elect Trump overtly championing trade tariffs on the campaign trail. The U.S. is one of the largest markets for Japan exports. And DXJ is heavily allocated to exporters. However, there’s some speculation Trump aims to use tariffs as a bargaining tool. There’s also speculation that the levies are unlikely to be deployed to the fullest extent.Setup Still Favors Japan StocksInvestors are right to evaluate the various scenarios that could affect Japan stocks and ETFs such as DXJ as Trump readies to take the oath of office. But a case can be made that what’s good for U.S. equities could also spark gains for Japan equivalents. “It is worth noting that US equity-positive developments which Trump could pursue, such as tax-related initiatives, may only have a limited impact on Japanese equities,” noted Nikko. “Tax cuts and tax breaks could increase US [consumption. That, in theory,] would also boost demand for goods imported from Japan. However, such tax-related initiatives could be coupled with aggressive tariffs and a drive to encourage consumers to buy US-manufactured products rather than imported [goods. That] would not favour the Japanese export sector.” The asset manager added that Japan exporters likely priced in a Trump victory. So they are unlikely to be caught flat-footed should tariff talk gain momentum. There are long-running close ties between the U.S. and Japan. So the latter may not be a point of emphasis for the incoming president regarding tariffs. So while it’s possible Japan stocks face near-term headwinds, the medium- and long-term outlooks are more appealing.Trajectory Expected to Remain Unchanged for Longer Term“Concerns regarding security, in addition to worries related to US tariffs, may temporarily dampen sentiment. Still, the trajectory of Japanese equities is expected to remain unchanged over the longer term given the current health of corporate Japan,” added Nikko. This article was prepared as part of WisdomTree’s general paid sponsorship of VettaFi | ETF Trends. This specific content within and any opinions expressed therein belong solely to VettaFi and do not reflect the opinion or analysis of WisdomTree, its employees, or its affiliates. Content published on VettaFi | ETF Trends is provided for educational purposes only and should not be considered investment or tax advice. For investment or tax advice, please consult a financial professional.WisdomTree is an independent company, unaffiliated with VettaFi | ETF Trends. WisdomTree has not been involved with the preparation of the content supplied by VettaFi | ETF Trends. It does not guarantee, or assume any responsibility for its content. For more news, information, and analysis, visit the Modern Alpha Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.